PCV11 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT OR TOTAL KNEE REPLACEMENT IN COLOMBIA
| Autor: | Pereira, R, Duran, A, Lindner, L, Toro, W, Arango, CH |
|---|---|
| Zdroj: | In Value in Health 2009 12(7):A502-A502 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect